| # | Drug | Count |
|---|---|---|
| 0 | CYCLOPHOSPHAMIDE | 4 |
| 1 | CYCLOPHOSPHAMIDE FOR INJECTION | 4 |
| 2 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 4 |
| 3 | ETOPOSIDE | 4 |
| 4 | GEMCITABINE HYDROCHLORIDE | 4 |
| 5 | GLOFITAMAB | 4 |
| 6 | OXALIPLATIN | 4 |
| 7 | PREDNISONE | 4 |
| 8 | RITUXIMAB | 4 |
| 9 | DOXORUBICIN | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GLOFITAMAB | 4 | 0.0015 |
| 1 | GEMCITABINE HYDROCHLORIDE | 4 | 0.0001 |
| 2 | DOXORUBICIN HYDROCHLORIDE | 2 | 0.0001 |
| 3 | ETOPOSIDE | 4 | 0.0001 |
| 4 | OXALIPLATIN | 4 | 0.0001 |
| 5 | DOXORUBICIN | 3 | 0.0000 |
| 6 | CYCLOPHOSPHAMIDE FOR INJECTION | 4 | 0.0000 |
| 7 | CYCLOPHOSPHAMIDE | 4 | 0.0000 |
| 8 | RITUXIMAB | 4 | 0.0000 |
| 9 | PREDNISONE | 4 | 0.0000 |
| # | Drug class | Count |
|---|---|---|
| 0 | Alkylating Drug [EPC] | 4 |
| 1 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 4 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 4 |
| 3 | Corticosteroid [EPC] | 4 |
| 4 | Platinum-based Drug [EPC] | 4 |
| 5 | Topoisomerase Inhibitor [EPC] | 4 |
| 6 | Thalidomide Analog [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 4 | 0.0010 |
| 1 | Topoisomerase Inhibitor [EPC] | 4 | 0.0001 |
| 2 | Alkylating Drug [EPC] | 4 | 0.0000 |
| 3 | Platinum-based Drug [EPC] | 4 | 0.0000 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 4 | 0.0000 |
| 5 | Corticosteroid [EPC] | 4 | 0.0000 |
| 6 | Thalidomide Analog [EPC] | 1 | 0.0000 |